uniQure (QURE) Net Margin Growth (5y) (2021 - 2026)
uniQure (QURE) Net Margin Growth (5y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
uniQure |
2.88 Bn |
2.88 Bn |
3.34 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
765,036.00 |
| Dec 31, 2025 |
-33,279.00 |
| Sep 30, 2025 |
85,985.00 |
| Jun 30, 2025 |
205,523.00 |
| Mar 31, 2025 |
2.41 Mn |
| Dec 31, 2024 |
17,493.00 |
| Sep 30, 2024 |
31,615.00 |
| Jun 30, 2024 |
76,315.00 |
| Mar 31, 2024 |
167,138.00 |
| Dec 31, 2023 |
26,677.00 |
| Sep 30, 2023 |
-566,613.00 |
| Jun 30, 2023 |
-215,202.00 |
| Mar 31, 2023 |
-91,005.00 |
| Dec 31, 2022 |
106,986.00 |
| Sep 30, 2022 |
-284,944.00 |
| Jun 30, 2022 |
-742,898.00 |
| Mar 31, 2022 |
-199,438.00 |
| Dec 31, 2021 |
8,689.00 |
| Sep 30, 2021 |
-162,516.00 |
| Jun 30, 2021 |
55,972.00 |
